JPH09197629A - Processing method of silver halide photosensitive material - Google Patents
Processing method of silver halide photosensitive materialInfo
- Publication number
- JPH09197629A JPH09197629A JP8004588A JP458896A JPH09197629A JP H09197629 A JPH09197629 A JP H09197629A JP 8004588 A JP8004588 A JP 8004588A JP 458896 A JP458896 A JP 458896A JP H09197629 A JPH09197629 A JP H09197629A
- Authority
- JP
- Japan
- Prior art keywords
- developing
- silver halide
- ascorbic acid
- sensitive material
- developing solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 silver halide Chemical class 0.000 title claims abstract description 31
- 239000000463 material Substances 0.000 title claims abstract description 29
- 229910052709 silver Inorganic materials 0.000 title claims abstract description 24
- 239000004332 silver Substances 0.000 title claims abstract description 24
- 238000003672 processing method Methods 0.000 title claims abstract description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 29
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 22
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 14
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 14
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 13
- 239000000126 substance Substances 0.000 claims abstract description 9
- 150000001875 compounds Chemical group 0.000 claims abstract description 8
- 125000003277 amino group Chemical group 0.000 claims abstract description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 abstract description 16
- 230000002542 deteriorative effect Effects 0.000 abstract description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 22
- 239000000243 solution Substances 0.000 description 15
- 238000012545 processing Methods 0.000 description 12
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine Substances NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 description 4
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical class OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 4
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 4
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical class NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- JAGQEJXPXPGNJB-UHFFFAOYSA-N 2-[carboxymethyl(hydroxy)amino]acetic acid Chemical compound OC(=O)CN(O)CC(O)=O JAGQEJXPXPGNJB-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- DSVIHYOAKPVFEH-UHFFFAOYSA-N 4-(hydroxymethyl)-4-methyl-1-phenylpyrazolidin-3-one Chemical compound N1C(=O)C(C)(CO)CN1C1=CC=CC=C1 DSVIHYOAKPVFEH-UHFFFAOYSA-N 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- AKNUHUCEWALCOI-UHFFFAOYSA-N N-ethyldiethanolamine Chemical compound OCCN(CC)CCO AKNUHUCEWALCOI-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- XCFIVNQHHFZRNR-UHFFFAOYSA-N [Ag].Cl[IH]Br Chemical compound [Ag].Cl[IH]Br XCFIVNQHHFZRNR-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
- 230000006911 nucleation Effects 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 239000006174 pH buffer Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- CMCWWLVWPDLCRM-UHFFFAOYSA-N phenidone Chemical compound N1C(=O)CCN1C1=CC=CC=C1 CMCWWLVWPDLCRM-UHFFFAOYSA-N 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- ZUNKMNLKJXRCDM-UHFFFAOYSA-N silver bromoiodide Chemical compound [Ag].IBr ZUNKMNLKJXRCDM-UHFFFAOYSA-N 0.000 description 2
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium erythorbate Chemical compound [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 235000010265 sodium sulphite Nutrition 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- NATRVBHPDXDFPY-XAHCXIQSSA-N (2R)-2-[(1S,2R)-1,2,3-trihydroxypropyl]-2H-furan-5-one Chemical compound OC[C@@H](O)[C@H](O)[C@@H]1OC(=O)C=C1 NATRVBHPDXDFPY-XAHCXIQSSA-N 0.000 description 1
- ZMMZCADSCOTBGA-SFCRRXBPSA-N (2r)-2-[(1s,2s)-1,2-dihydroxypropyl]-3,4-dihydroxy-2h-furan-5-one Chemical compound C[C@H](O)[C@H](O)[C@H]1OC(=O)C(O)=C1O ZMMZCADSCOTBGA-SFCRRXBPSA-N 0.000 description 1
- LGBPWIAXPVUTMY-JLAZNSOCSA-N (2r)-3,4-dihydroxy-2-[(1s)-1-hydroxyethyl]-2h-furan-5-one Chemical compound C[C@H](O)[C@H]1OC(=O)C(O)=C1O LGBPWIAXPVUTMY-JLAZNSOCSA-N 0.000 description 1
- ILBBPBRROBHKQL-SAMGZKJBSA-N (2s)-3,4-dihydroxy-2-[(1r,2r)-1,2,3-trihydroxypropyl]-2h-furan-5-one Chemical compound OC[C@@H](O)[C@@H](O)[C@@H]1OC(=O)C(O)=C1O ILBBPBRROBHKQL-SAMGZKJBSA-N 0.000 description 1
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 description 1
- JHKKTXXMAQLGJB-UHFFFAOYSA-N 2-(methylamino)phenol Chemical compound CNC1=CC=CC=C1O JHKKTXXMAQLGJB-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- UXFQFBNBSPQBJW-UHFFFAOYSA-N 2-amino-2-methylpropane-1,3-diol Chemical compound OCC(N)(C)CO UXFQFBNBSPQBJW-UHFFFAOYSA-N 0.000 description 1
- JKFYKCYQEWQPTM-UHFFFAOYSA-N 2-azaniumyl-2-(4-fluorophenyl)acetate Chemical compound OC(=O)C(N)C1=CC=C(F)C=C1 JKFYKCYQEWQPTM-UHFFFAOYSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- CXMYWOCYTPKBPP-UHFFFAOYSA-N 3-(3-hydroxypropylamino)propan-1-ol Chemical compound OCCCNCCCO CXMYWOCYTPKBPP-UHFFFAOYSA-N 0.000 description 1
- DIOYEFVIHLBWJX-UHFFFAOYSA-N 3-(diethylamino)propanoic acid Chemical compound CCN(CC)CCC(O)=O DIOYEFVIHLBWJX-UHFFFAOYSA-N 0.000 description 1
- AJKLCDRWGVLVSH-UHFFFAOYSA-N 4,4-bis(hydroxymethyl)-1-phenylpyrazolidin-3-one Chemical compound N1C(=O)C(CO)(CO)CN1C1=CC=CC=C1 AJKLCDRWGVLVSH-UHFFFAOYSA-N 0.000 description 1
- SJSJAWHHGDPBOC-UHFFFAOYSA-N 4,4-dimethyl-1-phenylpyrazolidin-3-one Chemical compound N1C(=O)C(C)(C)CN1C1=CC=CC=C1 SJSJAWHHGDPBOC-UHFFFAOYSA-N 0.000 description 1
- BLFRQYKZFKYQLO-UHFFFAOYSA-N 4-aminobutan-1-ol Chemical compound NCCCCO BLFRQYKZFKYQLO-UHFFFAOYSA-N 0.000 description 1
- FQQGQVUWBXURTA-UHFFFAOYSA-N 4-ethyl-1-phenylpyrazolidin-3-one Chemical compound N1C(=O)C(CC)CN1C1=CC=CC=C1 FQQGQVUWBXURTA-UHFFFAOYSA-N 0.000 description 1
- ZZEYCGJAYIHIAZ-UHFFFAOYSA-N 4-methyl-1-phenylpyrazolidin-3-one Chemical compound N1C(=O)C(C)CN1C1=CC=CC=C1 ZZEYCGJAYIHIAZ-UHFFFAOYSA-N 0.000 description 1
- ZFIQGRISGKSVAG-UHFFFAOYSA-N 4-methylaminophenol Chemical compound CNC1=CC=C(O)C=C1 ZFIQGRISGKSVAG-UHFFFAOYSA-N 0.000 description 1
- LQGKDMHENBFVRC-UHFFFAOYSA-N 5-aminopentan-1-ol Chemical compound NCCCCCO LQGKDMHENBFVRC-UHFFFAOYSA-N 0.000 description 1
- FIARATPVIIDWJT-UHFFFAOYSA-N 5-methyl-1-phenylpyrazolidin-3-one Chemical compound CC1CC(=O)NN1C1=CC=CC=C1 FIARATPVIIDWJT-UHFFFAOYSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-MVHIGOERSA-N D-ascorbic acid Chemical compound OC[C@@H](O)[C@@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-MVHIGOERSA-N 0.000 description 1
- PQUCIEFHOVEZAU-UHFFFAOYSA-N Diammonium sulfite Chemical compound [NH4+].[NH4+].[O-]S([O-])=O PQUCIEFHOVEZAU-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- CIWBSHSKHKDKBQ-VHUNDSFISA-N L-isoascorbic acid Chemical compound OC[C@H](O)[C@@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-VHUNDSFISA-N 0.000 description 1
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 1
- OPKOKAMJFNKNAS-UHFFFAOYSA-N N-methylethanolamine Chemical compound CNCCO OPKOKAMJFNKNAS-UHFFFAOYSA-N 0.000 description 1
- WUGQZFFCHPXWKQ-UHFFFAOYSA-N Propanolamine Chemical compound NCCCO WUGQZFFCHPXWKQ-UHFFFAOYSA-N 0.000 description 1
- 229910021612 Silver iodide Inorganic materials 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- SJOOOZPMQAWAOP-UHFFFAOYSA-N [Ag].BrCl Chemical compound [Ag].BrCl SJOOOZPMQAWAOP-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- XIWMTQIUUWJNRP-UHFFFAOYSA-N amidol Chemical compound NC1=CC=C(O)C(N)=C1 XIWMTQIUUWJNRP-UHFFFAOYSA-N 0.000 description 1
- LHIJANUOQQMGNT-UHFFFAOYSA-N aminoethylethanolamine Chemical compound NCCNCCO LHIJANUOQQMGNT-UHFFFAOYSA-N 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- BBLSYMNDKUHQAG-UHFFFAOYSA-L dilithium;sulfite Chemical compound [Li+].[Li+].[O-]S([O-])=O BBLSYMNDKUHQAG-UHFFFAOYSA-L 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 150000002429 hydrazines Chemical class 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- CRVGTESFCCXCTH-UHFFFAOYSA-N methyl diethanolamine Chemical compound OCCN(C)CCO CRVGTESFCCXCTH-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000006179 pH buffering agent Substances 0.000 description 1
- ATGAWOHQWWULNK-UHFFFAOYSA-I pentapotassium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [K+].[K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O ATGAWOHQWWULNK-UHFFFAOYSA-I 0.000 description 1
- HWGNBUXHKFFFIH-UHFFFAOYSA-I pentasodium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O HWGNBUXHKFFFIH-UHFFFAOYSA-I 0.000 description 1
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 description 1
- 229940043349 potassium metabisulfite Drugs 0.000 description 1
- 235000010263 potassium metabisulphite Nutrition 0.000 description 1
- BHZRJJOHZFYXTO-UHFFFAOYSA-L potassium sulfite Chemical compound [K+].[K+].[O-]S([O-])=O BHZRJJOHZFYXTO-UHFFFAOYSA-L 0.000 description 1
- 235000019252 potassium sulphite Nutrition 0.000 description 1
- NDGRWYRVNANFNB-UHFFFAOYSA-N pyrazolidin-3-one Chemical class O=C1CCNN1 NDGRWYRVNANFNB-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 description 1
- 229940045105 silver iodide Drugs 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000010352 sodium erythorbate Nutrition 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- UOULCEYHQNCFFH-UHFFFAOYSA-M sodium;hydroxymethanesulfonate Chemical compound [Na+].OCS([O-])(=O)=O UOULCEYHQNCFFH-UHFFFAOYSA-M 0.000 description 1
- PVGBHEUCHKGFQP-UHFFFAOYSA-N sodium;n-[5-amino-2-(4-aminophenyl)sulfonylphenyl]sulfonylacetamide Chemical compound [Na+].CC(=O)NS(=O)(=O)C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 PVGBHEUCHKGFQP-UHFFFAOYSA-N 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Silver Salt Photography Or Processing Solution Therefor (AREA)
Abstract
(57)【要約】
【課題】アスコルビン酸を現像主薬とするハロゲン化銀
感光材料の現像液において、長期にわたって現像処理を
行っても現像進行性を低下させることなくpHが急激に低
下しない方法を提供する。
【解決手段】ハロゲン化銀写真感光材料を、化2で表さ
れる化合物の少なくとも一種類を含む、アスコルビン酸
又はその誘導体を現像主薬とする現像液で処理する事を
特徴とする現像処理方法。
【化1】
【化2】
式中X、Y、Z、V、Wは水素原子、ヒドロキシル基、
カルボキシル基またはアミノ基を表す。l,m,n,
p,qは1以上の整数を表す。(57) Abstract: A method of developing a developing solution of a silver halide light-sensitive material containing ascorbic acid as a developing agent, the pH of which does not drop sharply without deteriorating the development progress even when the developing treatment is carried out for a long period of time. provide. A development processing method is characterized in that a silver halide photographic light-sensitive material is processed with a developing solution containing ascorbic acid or a derivative thereof containing at least one compound represented by Chemical formula 2, as a developing agent. Embedded image Embedded image In the formula, X, Y, Z, V and W are hydrogen atom, hydroxyl group,
Represents a carboxyl group or an amino group. l, m, n,
p and q represent an integer of 1 or more.
Description
【0001】[0001]
【産業上の利用分野】本発明は、ハロゲン化銀感光材料
の現像処理方法に関するものである。詳しくは、アスコ
ルビン酸を現像主薬とする現像液で、ハロゲン化銀感光
材料を長期にわたって現像処理を安定に行う方法に関す
るものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method of developing and processing a silver halide light-sensitive material. More specifically, the present invention relates to a method for stably developing a silver halide photosensitive material over a long period of time using a developing solution containing ascorbic acid as a developing agent.
【0002】[0002]
【従来の技術】ハロゲン化銀感光材料は、露光により像
を形成した後、画像を得るためには現像処理工程が必須
である。この処理工程にはハロゲン化銀感光材料の種類
によりその処理方法、処理剤が異なる。例えば黒白写真
感光材料における代表的処理工程としては、現像、定
着、水洗、乾燥であり、この他に漂白、安定化等の工程
が必要な場合もある。2. Description of the Related Art A silver halide light-sensitive material requires a development step in order to obtain an image after forming an image by exposure. In this processing step, the processing method and the processing agent differ depending on the type of silver halide light-sensitive material. For example, typical processing steps for black-and-white photographic light-sensitive materials are development, fixing, washing with water, and drying. In addition, steps such as bleaching and stabilization may be required.
【0003】このハロゲン化銀感光材料を処理するため
に用いる白黒現像液において、通常用いられる現像主薬
はハイドロキノンのようなシ゛ヒト゛ロキシヘ゛ンセ゛ン系のものが一
般的である。ところが近年、ハイドロキノンはその毒性
や廃液の公害負荷(高いCOD、BOD)が問題になってきて
いる。ハイドロキノンを使用する場合、ハイドロキノン
自身だけでなく、これを含む処理剤キットの濃縮液を作
るときに使用するジエチレングリコールやトリエチレン
グリコール等の溶媒や、ハイドロキノンの酸化防止剤と
して不可欠な亜硫酸塩が、更にCOD、BODを上げてしまう
ので、結果として非常に公害負荷が大きくなる。In the black-and-white developing solution used for processing the silver halide light-sensitive material, the developing agent usually used is generally dichtoxybenzene type such as hydroquinone. However, in recent years, the toxicity of hydroquinone and the pollution load of waste liquid (high COD, BOD) have become problems. When using hydroquinone, not only hydroquinone itself, but also solvents such as diethylene glycol and triethylene glycol used when making concentrated solutions of treating agent kits containing this, and sulfite salts that are indispensable as antioxidants of hydroquinone, Since COD and BOD are increased, as a result, the pollution load becomes very large.
【0004】更に亜硫酸塩は、現像液中にハロゲン化銀
の溶剤として作用し、現像液中に溶解した銀イオンは還
元されていわゆる銀汚れを引き起こすことは良く知られ
ている。これはハイドロキノンを使う限り不可避な問題
である。このためには感度等を犠牲にしてまで銀汚れ防
止剤を添加するなどの対策を必要とする。Further, it is well known that sulfite acts as a solvent for silver halide in the developing solution, and silver ions dissolved in the developing solution are reduced to cause so-called silver stain. This is an unavoidable problem as long as hydroquinone is used. To this end, it is necessary to take measures such as adding a silver stain preventing agent at the expense of sensitivity and the like.
【0005】そこで、近年アスコルビン酸を現像主薬と
して用いる現像液が注目されている。アスコルビン酸を
現像主薬として用いる場合、毒性は低く、又、ハイドロ
キノンと比べて水溶性が高く、ジエチレングリコール等
の溶媒を使う必要がない。更には亜硫酸塩を大幅に減ら
すことが出来るために銀汚れが減少する。Therefore, in recent years, a developer using ascorbic acid as a developing agent has attracted attention. When ascorbic acid is used as a developing agent, its toxicity is low, its water solubility is higher than that of hydroquinone, and it is not necessary to use a solvent such as diethylene glycol. Furthermore, since the amount of sulfite can be greatly reduced, silver stain is reduced.
【0006】ところがアスコルビン酸を現像主薬とする
場合、ハイドロキノンとは異なる問題が発生する。すな
わち、ハロゲン化銀感光材料を大量に処理すると、ハイ
ドロキノンに比べて急激にpHが低下する。このため、
ハイドロキノンに比べて少ない処理量で処理活性が低く
なり、問題となっている。However, when ascorbic acid is used as a developing agent, a problem different from hydroquinone occurs. That is, when a large amount of silver halide light-sensitive material is processed, the pH is drastically lowered as compared with hydroquinone. For this reason,
This is a problem because the treatment activity becomes lower with a smaller amount of treatment than that of hydroquinone.
【0007】この問題に対して、例えば特開平5−31
3318では酸化還元電極を用いてpH値をモニターし、
アルカリ溶液を用いてpH値を管理している。この方法で
はpHに対する電極の感度が問題となったり、あるいは
長期の停機に空気酸化でpHが低下した場合にアルカリ
でpHを変えると現像主薬の濃度が極端に減少することと
なり、問題である。特開平6−19069では炭酸イオ
ンをハイドロキノンを現像主薬とした現像液よりも多
い、0.5モル/リットル以上添加するとしている。しかしながら
炭酸塩を多量に添加すると、ハロゲン化銀感光材料の現
像進行性を低下させる傾向がある。又、特開平7−92
627では補充液のpHをスタート液に比べて0.15以上高
くしてランニング時のpHを維持するとしている。しかし
ながらこの方法では補充間隔や補充量を細かく決めてお
かなければならず、使用方法が煩雑になるという問題が
ある。To solve this problem, for example, Japanese Patent Laid-Open No. 5-31
The 3318 monitors the pH value using a redox electrode,
The pH value is controlled using an alkaline solution. This method is problematic in that the sensitivity of the electrode to pH becomes a problem, or when the pH is lowered by air oxidation for a long period of suspension and the pH is changed with an alkali, the concentration of the developing agent is extremely decreased. In JP-A-6-19069, it is stated that carbonate ion is added in an amount of 0.5 mol / liter or more, which is larger than in a developer using hydroquinone as a developing agent. However, when a large amount of a carbonate is added, the progress of development of the silver halide light-sensitive material tends to decrease. Also, JP-A-7-92
In 627, the pH of the replenisher is set to be 0.15 or more higher than that of the starter to maintain the pH during running. However, in this method, the replenishment interval and the replenishment amount must be determined in detail, and there is a problem that the method of use becomes complicated.
【0008】[0008]
【発明が解決しようとする課題】本発明の目的は、アス
コルビン酸またはその誘導体を現像主薬とするハロゲン
化銀感光材料の現像液において、長期にわたって現像処
理を行っても現像性を低下させることなくpHが急激に低
下しない簡便な方法を提供することである。SUMMARY OF THE INVENTION An object of the present invention is to provide a developing solution for a silver halide photosensitive material containing ascorbic acid or a derivative thereof as a developing agent without deteriorating the developing property even if the developing process is carried out for a long period of time. An object is to provide a simple method in which the pH does not drop rapidly.
【0009】[0009]
【課題を解決するための手段】本発明の上記目的は、ハ
ロゲン化銀写真感光材料を、化3または化4で表される
化合物の少なくとも一種類を含む、アスコルビン酸又は
その誘導体を現像主薬とする現像液で処理する事を特徴
とする現像処理方法を用いることで達成された。The above object of the present invention is to provide a silver halide photographic light-sensitive material containing ascorbic acid or a derivative thereof containing at least one compound represented by Chemical formula 3 or Chemical formula 4 as a developing agent. It was achieved by using a development processing method characterized by processing with a developing solution.
【0010】[0010]
【化3】 Embedded image
【0011】[0011]
【化4】 Embedded image
【0012】式中X、Y、Z、V、Wは水素原子、ヒド
ロキシル基、カルボキシル基またはアミノ基を表す。
l,m,n,p,qは1以上の整数を表す。In the formula, X, Y, Z, V and W represent a hydrogen atom, a hydroxyl group, a carboxyl group or an amino group.
l, m, n, p and q represent integers of 1 or more.
【0013】以下に化3、化4で表される化合物の具体
例を示すが、本発明において、これらに限定されるもの
ではない。、ジエタノールアミン、トリエタノールアミ
ン、ジイソプロパノールアミン、N−メチルエタノール
アミン、N−アミノエチルエタノールアミン、N,N−
ジブチルブタノールアミン、N,N−ジエチルエタノー
ルアミン、N,N−ジメチルエタノールアミン、N−メ
チルジエタノールアミン、N−エチルジエタノールアミ
ン、3−アミノプロパノール、1−アミノ−プロパン−
2−オール、4−アミノブタノール、5−アミノ−ペン
タン−1−オール、3,3’−イミノジプロパノール、
N−エチル−2,2’−イミノジエタノール、2−アミ
ノ−2−(ヒドロキシメチル)プロパン−1,3−ジオ
ール、2−アミノ−2−メチルプロパン−1,3−ジオ
ール、3-ジエチルアミノプロパン酸、ヒドロキシイミノ
2酢酸、トリメチルアミン、トリエチルアミン、などが
挙げられる。Specific examples of the compounds represented by Chemical formulas 3 and 4 are shown below, but the invention is not limited thereto. , Diethanolamine, triethanolamine, diisopropanolamine, N-methylethanolamine, N-aminoethylethanolamine, N, N-
Dibutylbutanolamine, N, N-diethylethanolamine, N, N-dimethylethanolamine, N-methyldiethanolamine, N-ethyldiethanolamine, 3-aminopropanol, 1-amino-propane-
2-ol, 4-aminobutanol, 5-amino-pentan-1-ol, 3,3′-iminodipropanol,
N-ethyl-2,2'-iminodiethanol, 2-amino-2- (hydroxymethyl) propane-1,3-diol, 2-amino-2-methylpropane-1,3-diol, 3-diethylaminopropanoic acid , Hydroxyiminodiacetic acid, trimethylamine, triethylamine, and the like.
【0014】本発明に用いられる化合物は現像液の使用
液1リットル当たり0.05〜1.5モルが好ましく、0.3〜0.9モル含
有することがより好ましい。The amount of the compound used in the present invention is preferably 0.05 to 1.5 mol, and more preferably 0.3 to 0.9 mol, per liter of the developer used.
【0015】本発明に用いられるハロゲン化銀感光材料
は黒白写真材料(例えば、医療用または工業用X線写真
材料、リス型写真材料などの写真製版用感光材料、マイ
クロ写真材料、X線用マイクロ反転写真材料、電算写植
用ペーパー、一般撮影用ネガ写真材料、印画紙など)が
ある。The silver halide light-sensitive material used in the present invention is a black-and-white photographic material (for example, a medical or industrial X-ray photographic material, a photolithographic light-sensitive material such as a lith type photographic material, a micro-photographic material, an X-ray micro material. Inverse photographic material, computer typesetting paper, negative photographic material for general photography, photographic paper, etc.).
【0016】又、グラフィックアーツの分野では、網点
画像による連続階調の再生を良好にするために、超硬調
な写真特性が得られる画像生成システムが必要で、ヒド
ラジン化合物を乳剤中もしくは現像液に添加することが
知られている。特開平7−258782はヒドラジンや
その造核を促進する物質を感光材料に含有させ、アスコ
ルビン酸を含む現像液で処理する方法が記載されてい
る。本発明の現像液はそれらの感光材料を用いることが
出来る。Further, in the field of graphic arts, an image forming system capable of obtaining super-high contrast photographic characteristics is required in order to improve reproduction of continuous gradation by a halftone dot image, and a hydrazine compound is used in an emulsion or a developing solution. It is known to add. JP-A-7-258782 describes a method in which hydrazine or a substance that promotes nucleation thereof is contained in a photosensitive material and is processed with a developing solution containing ascorbic acid. These photosensitive materials can be used for the developer of the present invention.
【0017】又、特開昭61−267759号にはヒト゛ラ
シ゛ン化合物と硬調化を促進するアミノ化合物を現像液に
添加する方法、特開昭60−179734号、米国特許
5,104,769号、同4,798,780号には硬
調化作用の高い種々のヒドラジン化合物を用いる方法、
特開平1−179939号、同1−179940号では
造核促進剤とヒドラジン化合物とを併用する方法、更
に、米国特許4,998,604号、同4,994,3
65号にも類似の硬調化の方法が記載されているが、こ
れらに記載されているヒドラジン化合物を含有する感光
材料の処理に本発明の処理方法を用いることが出来る。
この場合、本発明の化3、化4の化合物は、硬調化を促
進するアミノ化合物を含む現像液であってもその効果は
阻害されない。Further, JP-A-61-267759 discloses a method of adding a human hydrazine compound and an amino compound which promotes contrast enhancement to a developing solution, JP-A-60-179734 and US Pat. No. 5,104,769. No. 4,798,780, a method using various hydrazine compounds having a high contrast-increasing effect,
JP-A-1-179939 and JP-A-1-179940 disclose a method in which a nucleation accelerator and a hydrazine compound are used in combination, and further, US Pat. Nos. 4,998,604 and 4,994,3.
No. 65 describes a similar method for increasing the contrast, but the processing method of the present invention can be used for processing a light-sensitive material containing a hydrazine compound described therein.
In this case, the effects of the compounds of Chemical formulas 3 and 4 of the present invention are not impaired even if the developer contains an amino compound that promotes contrast enhancement.
【0018】上記感光材料の感光性ハロゲン化銀乳剤層
に用いるハロゲン化銀には特に限定はなく、塩臭化銀、
塩ヨウ臭化銀、ヨウ臭化銀、臭化銀などを用いることが
出来るが、塩ヨウ臭化銀又は、ヨウ臭化銀を用いる場合
には、ヨウ化銀の含有量は、5モル%以下であることが
好ましい。ハロゲン化銀粒子の形態、癖晶、サイス゛分布等
には特に限定はないが、平均粒子径0.7ミクロン以下
のもの、特に0.5ミクロン以下のものが好ましく、か
つ、全粒子数の90%以上が平均粒子径の±10%の範
囲の粒子径を有するものが好ましい。ハロゲン化銀乳剤
の調整方法は順混合、逆混合、同時混合など公知の方法
のいずれであってもよい。The silver halide used in the photosensitive silver halide emulsion layer of the above light-sensitive material is not particularly limited, and silver chlorobromide,
Although silver chloroiodobromide, silver iodobromide, silver bromide, etc. can be used, when silver chloroiodobromide or silver iodobromide is used, the content of silver iodide is 5 mol%. The following is preferable. The morphology, habit crystals, and size distribution of the silver halide grains are not particularly limited, but those having an average grain size of 0.7 micron or less, particularly 0.5 micron or less are preferable, and the total number of grains is 90. % Or more preferably has a particle size within the range of ± 10% of the average particle size. The method for preparing the silver halide emulsion may be any of known methods such as forward mixing, reverse mixing, and simultaneous mixing.
【0019】本発明の現像液に用いられるアスコルヒ゛ン酸又
はその誘導体、例えば、L-アスコルビン酸、D-アスコル
ビン酸、L-エリスロアスコルビン酸、D-グルコアスコル
ビン酸、6-デオキシ-L-アスコルビン酸、L-ラムノアス
コルビン酸、D-グルコヘプトアスコルビン酸、イミノ-L
-エリスロアスコルビン酸、イミノ-D-グルコアスコルビ
ン酸、イミノ-6-デオキシ-L-アスコルビン酸、イミノ-D
-グルコヘプトアスコルビン酸、グリコアスコルビン
酸、D-ガラクトアスコルビン酸、L-アラボアスコルビン
酸、ソルボアスコルビン酸、イソアスコルビン酸ナトリ
ウム、アスコルビン酸ナトリウム等が挙げられる。これ
らの化合物はアルカリ金属等の塩であってもよい。Ascorbic acid or its derivative used in the developing solution of the present invention, for example, L-ascorbic acid, D-ascorbic acid, L-erythroascorbic acid, D-glucoascorbic acid, 6-deoxy-L-ascorbic acid, L-rhamnoascorbic acid, D-glucoheptoascorbic acid, imino-L
-Erythroascorbic acid, imino-D-glucoascorbic acid, imino-6-deoxy-L-ascorbic acid, imino-D
-Glucoheptoascorbic acid, glycoascorbic acid, D-galactoascorbic acid, L-araboascorbic acid, sorboascorbic acid, sodium isoascorbate, sodium ascorbate and the like can be mentioned. These compounds may be salts of alkali metals and the like.
【0020】本発明で用いられるアスコルビン酸現像液
においては、補助となる超加成性現像主薬を用いること
が好ましい。この例としては3-ピラゾリドン類(例え
ば、1-フェニル-3-ピラゾリドン、1-フェニル-4-メチル
-3-ピラゾリドン、1-フェニル-4,4-ジメチル-3-ピラゾ
リドン、1-フェニル-4-エチル-3-ピラゾリドン、1-フェ
ニル-5-メチル-3-ピラゾリドン、1-フェニル-4-メチル-
4-ヒドロキシメチル-3-ピラゾリドン、1-フェニル-4,4-
ジヒドロキシメチル-3-ピラゾリドンなど)、アミノフ
ェノール類(例えばo-アミノフェノール、p-アミノフェ
ノール、N-メチル-o-アミノフェノール、N-メチル-p-ア
ミノフェノール、2,4-ジアミノフェノールなど)、1-ア
リール-3-アミノピラゾリドン類(例えば1-(p-ヒドロ
キシフェニル)-3-アミノピラゾリドン、1-(p-メチル
アミノフェニル)-3-アミノピラゾリドン、1-(p-アミ
ノ-m-メチルフェニル)-3-アミノピラゾリドンなど)等
あるいはこれらの混合物である。本発明に使用する白黒
現像液に用いる現像主薬には良好な性能を得易い点でア
スコルビン酸類と1-フェニル-3-ピラゾリドン類の組合
せが最も好ましい。この他にp-アミノフェノール系現像
主薬を含んでもよい。In the ascorbic acid developer used in the present invention, it is preferable to use an auxiliary super-additive developing agent. Examples of this include 3-pyrazolidones (eg, 1-phenyl-3-pyrazolidone, 1-phenyl-4-methyl
-3-pyrazolidone, 1-phenyl-4,4-dimethyl-3-pyrazolidone, 1-phenyl-4-ethyl-3-pyrazolidone, 1-phenyl-5-methyl-3-pyrazolidone, 1-phenyl-4-methyl -
4-hydroxymethyl-3-pyrazolidone, 1-phenyl-4,4-
Dihydroxymethyl-3-pyrazolidone, etc.), aminophenols (eg, o-aminophenol, p-aminophenol, N-methyl-o-aminophenol, N-methyl-p-aminophenol, 2,4-diaminophenol, etc.) , 1-aryl-3-aminopyrazolidones (eg, 1- (p-hydroxyphenyl) -3-aminopyrazolidone, 1- (p-methylaminophenyl) -3-aminopyrazolidone, 1- ( p-amino-m-methylphenyl) -3-aminopyrazolidone or the like, or a mixture thereof. The combination of ascorbic acids and 1-phenyl-3-pyrazolidones is most preferred for the developing agent used in the black-and-white developer used in the present invention because good performance is easily obtained. In addition, a p-aminophenol-based developing agent may be contained.
【0021】この他にL.F.Mason Photographic Process
ing Chemistry(Focal Press刊.1966年)の226〜229
頁、特開昭48-64933号等に記載のものを用いてもよい。In addition to this, LF Mason Photographic Process
ing Chemistry (Focal Press, 1966) 226-229
And those described in JP-A-48-64933 may be used.
【0022】これらの現像主薬は通常0.1〜80g/l、好ま
しくは0.2〜50g/l程度用いられる。このうち超加成性を
示す補助現像主薬は1〜10重量%含有することが好まし
い。These developing agents are usually used in an amount of 0.1 to 80 g / l, preferably 0.2 to 50 g / l. Of these, the auxiliary developing agent exhibiting superadditivity is preferably contained in an amount of 1 to 10% by weight.
【0023】本発明の現像液においては亜硫酸イオンを
大量に添加する必要がない。しかしながら、全く添加し
ない場合は保存性が悪くなる為に少量添加することが好
ましい。亜硫酸塩は、例えば亜硫酸ナトリウム、亜硫酸
カリウム、亜硫酸リチウム、亜硫酸アンモニウム、重亜
硫酸ナトリウム、メタ重亜硫酸カリウム、ホルムアルデ
ヒド重亜硫酸ナトリウム等を用いることが出来る。亜硫
酸イオンの添加量は0.01〜0.3モル/リットルが好ましい。In the developer of the present invention, it is not necessary to add a large amount of sulfite ion. However, if it is not added at all, the storability deteriorates, so it is preferable to add a small amount. As the sulfite, for example, sodium sulfite, potassium sulfite, lithium sulfite, ammonium sulfite, sodium bisulfite, potassium metabisulfite, formaldehyde sodium bisulfite and the like can be used. The amount of sulfite ion added is preferably 0.01 to 0.3 mol / liter.
【0024】本発明に用いる現像液のpHは9〜13までの
範囲のものが好ましい。更に好ましくはpH9.0〜12まで
の範囲である。pHの調整の為に用いる化合物として化
3、化4で示される化合物のほかに水酸化ナトリウム、
水酸化カリウム、炭酸ナトリウム、炭酸カリウム、第三
リン酸ナトリウム、第三リン酸カリウムのような無機化
合物を含んでもよい。The pH of the developer used in the present invention is preferably in the range of 9 to 13. More preferably, it is in the range of pH 9.0 to 12. In addition to the compounds shown in Chemical formulas 3 and 4, sodium hydroxide,
Inorganic compounds such as potassium hydroxide, sodium carbonate, potassium carbonate, sodium triphosphate, potassium triphosphate may be included.
【0025】上記成分以外に用いられる添加剤として
は、臭化ナトリウム、ヨウ化カリウムのような現像抑制
剤、エチレングリコール、ジエチレングリコール、トリ
エチレングリコール、ジメチルホルムアミド、メチルセ
ロソルブ、ヘキシレングリコール、エタノール、メタノ
ールのような有機溶剤を含んでもよく、更に必要に応じ
て色調剤、消泡剤、硬水軟化剤などを含んでもよい。As additives used in addition to the above components, development inhibitors such as sodium bromide and potassium iodide, ethylene glycol, diethylene glycol, triethylene glycol, dimethylformamide, methyl cellosolve, hexylene glycol, ethanol, methanol. Such an organic solvent may be contained, and if necessary, a toning agent, a defoaming agent, a water softening agent and the like may be contained.
【0026】[0026]
【実施例】以下に実施例を掲げ本発明を詳細に説明する
が、これだけに限定されるわけではない。The present invention will be described in detail with reference to the following Examples, but it should not be construed that the invention is limited thereto.
【0027】実施例 現像液 水 600ml 亜硫酸ナトリウム 10g pH緩衝剤 Xモル アスコルビン酸 30g 1-フェニル-4-ヒドロキシメチル- 4-メチル-3-ピラゾリドン 0.7g ベンゾトリアゾール 0.2g NaBr 1.5g エチレンジアミン四酢酸二ナトリウム塩 1g 水を加えて1Lとした後、KOHでpHを10.50
(25℃)に合わせた。Example developer water 600 ml sodium sulfite 10 g pH buffer X mol ascorbic acid 30 g 1-phenyl-4-hydroxymethyl-4-methyl-3-pyrazolidone 0.7 g benzotriazole 0.2 g NaBr 1.5 g ethylenediamine tetra Acetic acid disodium salt 1 g After adding water to make 1 L, pH was adjusted to 10.50 with KOH.
(25 ° C.).
【0028】上記現像処理液のpH緩衝剤として炭酸カ
リウムを1リットルあたり0.5モル、1.0モル添加した
ものを、比較例1、比較例2とする。また、pH緩衝剤
としてジエタノールアミン、トリエタノールアミン、ヒ
ドロキシイミノ2酢酸、トリエチルアミンを1リットル
当たり1モル添加したものを本発明1、2、3、4とす
る。Comparative Examples 1 and 2 are prepared by adding 0.5 mol and 1.0 mol of potassium carbonate per liter as a pH buffering agent to the above developing solution. Moreover, what added 1 mol of diethanolamine, triethanolamine, hydroxyiminodiacetic acid, and triethylamine as a pH buffer agent per liter is set as this invention 1, 2, 3, 4.
【0029】LD221(大日本スクリーン(株)製自
動現像機)の現像槽に比較例1、2および本発明1〜4
の現像液を入れ、定着槽に定着液として三菱製紙(株)
製のCF901を入れた。明室用フィルム感材(DCL
−EHF商品名(三菱製紙(株)製))を明室用反転プ
リンターP617(大日本スクリーン(株)製)でステ
ップウェッジを通して露光したものを38℃20秒で処
理した。また、同様に、明室用フィルム感材を画像が全
体の50%になるような原稿を露光し、1リットル当た
り10m2処理した後に、同様にステップウェッジを露
光したDCL−EHFを処理した。Comparative Examples 1 and 2 and Inventions 1 to 4 were used in a developing tank of LD221 (automatic developing machine manufactured by Dainippon Screen Co., Ltd.).
The developer is added and the fixer is used as a fixer in Mitsubishi Paper Mills Ltd.
CF901 manufactured by K.K. Light sensitive film for light room (DCL
-EHF trade name (manufactured by Mitsubishi Paper Mills, Ltd.) was exposed through a step wedge with a reversing printer for light room P617 (manufactured by Dainippon Screen Co., Ltd.) and processed at 38 ° C for 20 seconds. Similarly, a light-sensitive film light-sensitive material was exposed to a document such that the image was 50% of the whole, and after processing 10 m 2 per liter, DCL-EHF similarly exposed to a step wedge was processed.
【0030】上記方法によって作成したウエッジサンプ
ルの最高濃度(Dmax)、最低濃度(Dmin)及び感度の測定
はマクベス濃度計TR927を用いて行った。この測定
結果は表1、表2に示した。表1、表2において感度は
比較例1で透過濃度3.0を得るに要した露光量の逆数
を100として相対値で示した。The maximum density (Dmax), the minimum density (Dmin) and the sensitivity of the wedge sample prepared by the above method were measured using a Macbeth densitometer TR927. The measurement results are shown in Tables 1 and 2. In Tables 1 and 2, the sensitivities are shown as relative values with the reciprocal of the exposure amount required to obtain a transmission density of 3.0 in Comparative Example 1 being 100.
【0031】[0031]
【表1】 [Table 1]
【0032】[0032]
【表2】 [Table 2]
【0033】表1及び表2からわかるように、比較例1
の現像液は1リットル当たり10m2処理後にpHが極端に下っ
て写真特性が大きく変化し、又、比較例2の現像液では
pHは変化しないものの最初から感度及び最高濃度が低
い。これ対して本発明の現像液は、初期の処理でも10m2
処理後でも写真特性が変化せず、安定に処理を行うこと
ができた。又、本発明の現像液は初期状態のpHからの変
化も問題にならないくらいに小さかった。As can be seen from Tables 1 and 2, Comparative Example 1
The developing solution of No. 2 had a drastic drop in pH after treatment of 10 m 2 per liter, and the photographic characteristics changed significantly. Further, the developing solution of Comparative Example 2 had no change in pH, but the sensitivity and the maximum density were low from the beginning. On the other hand, the developer of the present invention is 10 m 2 even in the initial processing.
Even after the processing, the photographic characteristics did not change, and the processing could be performed stably. Further, the developer of the present invention was so small that the change from the initial pH was not a problem.
【0034】[0034]
【発明の効果】本発明によれば、ハロゲン化銀感光材料
用の現像処理液に於て、現像活性を落とすことなく安定
なpHを維持することができる。According to the present invention, it is possible to maintain a stable pH in a developing solution for a silver halide light-sensitive material without degrading the developing activity.
Claims (1)
は化2で表される化合物の少なくとも一種類を含む、ア
スコルビン酸またはその誘導体を現像主薬とする現像液
で処理する事を特徴とする現像処理方法。 【化1】 【化2】 式中X、Y、Z、V、Wは水素原子、ヒドロキシル基、
カルボキシル基またはアミノ基を表す。l,m,n,
p,qは1以上の整数を表す。1. A silver halide photographic light-sensitive material is treated with a developing solution containing ascorbic acid or a derivative thereof containing at least one compound represented by Chemical formula 1 or Chemical formula 2 as a developing agent. Development processing method. Embedded image Embedded image In the formula, X, Y, Z, V and W are hydrogen atom, hydroxyl group,
Represents a carboxyl group or an amino group. l, m, n,
p and q represent an integer of 1 or more.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8004588A JPH09197629A (en) | 1996-01-16 | 1996-01-16 | Processing method of silver halide photosensitive material |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8004588A JPH09197629A (en) | 1996-01-16 | 1996-01-16 | Processing method of silver halide photosensitive material |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH09197629A true JPH09197629A (en) | 1997-07-31 |
Family
ID=11588208
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8004588A Pending JPH09197629A (en) | 1996-01-16 | 1996-01-16 | Processing method of silver halide photosensitive material |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH09197629A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0877287A1 (en) * | 1997-05-09 | 1998-11-11 | Konica Corporation | Developer for silver halide light sensitive photographic material and processing method by use thereof |
-
1996
- 1996-01-16 JP JP8004588A patent/JPH09197629A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0877287A1 (en) * | 1997-05-09 | 1998-11-11 | Konica Corporation | Developer for silver halide light sensitive photographic material and processing method by use thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0778617B2 (en) | Silver halide photographic light-sensitive material | |
JPH06505574A (en) | Improved development system for films containing hydrazine | |
US4172728A (en) | High contrast continuous tone developer and process of use | |
EP0738400B1 (en) | Non-hydroquinone photographic developer composition and processing method | |
US4756990A (en) | Method of effecting high contrast development of an image-wise exposed photographic silver halide emulsion layer material | |
JPS6262333B2 (en) | ||
JPH09197629A (en) | Processing method of silver halide photosensitive material | |
US4741991A (en) | Stable photographic developer and replenisher therefor | |
JPH10198002A (en) | Black-and-white development processing method | |
JPH0756287A (en) | Formation of halogenated-silver photograph-developer composition and photograph silver image | |
JPH05313318A (en) | Method of controlling ph of ascorbic acid group developer | |
EP0786698B1 (en) | Organic/inorganic developer composition | |
EP0969317B1 (en) | Method of processing a photographic high contrast silver halide material | |
EP0969317A9 (en) | Method of processing a photographic high contrast silver halide material | |
JP3356616B2 (en) | Method for developing silver halide photosensitive material | |
US5604082A (en) | Method for processing an exposed photographic silver halide material | |
EP0239149B1 (en) | High contrast development of silver halide emulsion material | |
JP3177797B2 (en) | Method for developing black-and-white silver halide photographic materials | |
JP3473827B2 (en) | Silver halide photographic materials | |
JPH10123678A (en) | Processing method of silver halide photosensitive material | |
JP2002229161A (en) | Black-and-white developing composition and its use method | |
JPH09311419A (en) | Processing method of silver halide light-sensitive material | |
JPH07119969B2 (en) | Development agent kit for silver halide photosensitive materials | |
JP2002099067A (en) | Processing method of silver halide photosensitive material | |
JPH07168323A (en) | Method for developing silver halide photographic sensitive material |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |